Health
Spacing COVID-19 vaccine doses has benefits, but longer-term outcomes depend on robust immunity – EurekAlert
Delaying second doses of COVID-19 vaccines should reduce case numbers in the near term. But the longer-term case burden and the potential for evolution of viral…
Delaying second doses of COVID-19 vaccines should reduce case numbers in the near term. But the longer-term case burden and the potential for evolution of viral “escape” from immunity will depend on the robustness of immune responses generated by natural infections and one or two vaccine doses, according to a Princeton University and McGill University study published March 9 in the journal Science.
“Several countries including the United Kingdom and Canada have stated that they will delay second…
-
General21 hours agoDonald Trump and the ghost of Al Capone • Inside Story
-
General14 hours agoFrench far-right supporters rally against Le Pen conviction in Paris
-
Business5 hours ago1 ASX dividend stock down 43% I’d buy right now
-
Business9 hours agoBattle of the ASX ETFs: Why has VGS outperformed VTS this year?